Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.935 USD | -2.60% | 0.00% | +29.18% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.18% | 340M | |
+4.54% | 111B | |
+11.60% | 105B | |
-12.82% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.02% | 16.96B | |
+3.54% | 13.7B | |
+37.74% | 12.45B |
- Stock Market
- Equities
- AVIR Stock
- News Atea Pharmaceuticals, Inc.
- Atea Pharmaceuticals : Morgan Stanley Adjusts Price Target on Atea Pharmaceuticals to $37 From $35, Maintains Overweight Rating